No more glass? Disruptive technologies gain traction in digital pathology
Third Annual
Digital Pathology
Transforming Medicine in a Digital World
February 16-18, 2015 | Moscone North Convention Center | San Francisco, CA
www.triconference.com/digital-
UPMC’s Dr. Jeffrey Fine to Present at Third Annual Digital Pathology Conference – Part of the 22nd Annual Molecular Medicine Tri-Conference
Join 3,000 Informatics, Diagnostics, Clinical and Oncology Researchers in San Francisco
SPEAKER SPOTLIGHT: No More Glass: Optical Coherence Tomography (OCT) Permits Pathologist-Ready Photomicrographs without Microscope Slides
Jeffrey Fine, M.D., Assistant Professor, Pathology, University of Pittsburgh School of Medicine
Optical Coherence Tomography (OCT) is an advanced imaging technique that permits rapid non-destructive microscopic tissue imaging. Dr. Fine will provide a pathologist-friendly overview of OCT, followed by a summary of early ex-vivo imaging of breast and endometrial specimens. This work aims toward clinical application and toward OCT expertise that can support future in vivo applications. Dr. Fine will end with discussion of future trends for this technology. PubMed
REGISTER (SAVE up to $400, Register by November 28) |
Learn More | View Brochure
Scientific Advisory Board
- Kenneth J. Bloom, M.D., Chief Medical Officer, Clarient, Inc.
- Eric F. Glassy, M.D., FCAP, Medical Director, Affiliated Pathologists Medical Group
- Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center
- David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University
CONFERENCE-AT-A-GLANCE
DIGITAL PATHOLOGY PREDICTIONS: MARKET ANALYSIS & TRENDS
Mobile Industry: Exploiting Smartphones for Digital Pathology
Douglas J. Hartman, M.D., Assistant Professor, Pathology, University of Pittsburgh Medical Center
DIGITAL PATHOLOGY – Where We Have Been and the Future
Kim Dickinson, M.D., MBA, MPH, Medical Director, Lab Corp Clinical Trials; President, Digital Pathology Association
Luncheon Presentation
Sponsored by Definiens
IN VIVO MICROSCOPY
Gastrointestinal in vivo Microscopy: One Step Closer to Achieving the Fantastic Voyage
Gregory Y. Lauwers, M.D., Professor & Vice Chair, Pathology, Massachusetts General Hospital
No More Glass: Optical Coherence Tomography (OCT) Permits Pathologist-Ready Photomicrographs without Microscope Slides
Jeffrey Fine, M.D., Assistant Professor, Pathology, University of Pittsburgh School of Medicine
26 Easy Steps to Implementing an in vivo Microscopy Service in Pathology
Andrew Quinn, M.D., Fellow, Cytology, Pathology, Brigham and Women’s Hospital
Collaboration Across Multi Disciplinary Teams
Chrystal Adams, Associate Vice President, Marketing, XIFIN
Sponsored by XIFIN
> Sponsored Presentation (Opportunities Available)
LARGE SCALE DEPLOYMENT OF DIGITAL PATHOLOGY
Large Scale Deployment of Digital Pathology: The Importance of Color
Elizabeth A. Krupinski, Ph.D., Professor, Medical Imaging, University of Arizona
How Digital Pathology Enables New Business and Clinical Models in Pathology
Robert Michel, Editor-In-Chief, The Dark Report
Digital Pathology Patent Landscape: Insights into Emerging Trends and Opportunities
Sury Vepa, Ph.D., J.D., Senior Licensing and Patenting Manager, Office of Intramural Research; Office of Technology Transfer, NIH
Digital Pathology: Regulatory Barriers to Adoption
Eric F. Glassy, M.D., FCAP, Medical Director, Pathology, Affiliated Pathologist Group
QUANTITATIVE DETECTION OF BIOMARKERS FOR NEXT-GEN IMMUNOHISTOCHEMISTRY
Next-Generation Immunohistochemistry Using Multiplexed Ion Beam Imaging
Michael Angelo, M.D., Ph.D., Instructor, Pathology, Stanford University
Multiplexed Immunofluorescence in Translational Research and Clinical Applications
Michael D. Feldman, M.D., Ph.D., Associate Professor, Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania
Domain Specific Antibodies as Biomarkers?
David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University School of Medicine
> Sponsored Presentations (Opportunities Available)
Breakout Discussions in the Exhibit Hall
Informatics Role in the Changing Healthcare Environment
Substantiating the Value of Whole Slide Imaging
Digital Pathology Interoperability
SPECIALIZED ADOPTION OF DIGITAL PATHOLOGY
Remote Eye Tracking to Assess Pathologist Interaction with Digital Whole Slide Images
Beverly E. Faulkner-Jones, M.D., Ph.D., Staff Pathologist, Pathology, Beth Israel Deaconess Medical Center
High Resolution Histology 3D Reconstruction and Analysis
Yukako Yagi, Ph.D., Director, MGH Pathology Imaging & Communication Technology (PICT) Center, Massachusetts General Hospital; Affiliated Faculty, Wellman Center for Photomedicine, Massachusetts General Hospital; Assistant Professor of Pathology, Harvard Medical School
Google Glass for Pathology
Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center
BIG DATA AND THE CLOUD
Whole Slide Imaging Data Storage: A “Dickens” of a Tale — “Please Sir, Can I Have Another Petabyte?”
Michael W. Riben, M.D., Medical Director, Laboratory Informatics; Associate Professor, Pathology, MD Anderson Cancer Center
WSI, BIOIMAGING & BIOINFORMATICS RESEARCH
Hot Spot Detection for Histopathological Images
Metin N. Gurcan, Ph.D., Associate Professor, Biomedical Informatics, The Ohio State University
Reimagining Cancer: The Opportunities and Challenges of Biomarker-Driven, Targeted Therapy
Mark Boguski, M.D., Ph.D., Founder & CMO, Genome Health Solutions
NEXT STEPS FOR INTEGRATION: MOVING DIGITAL PATHOLOGY INTO REAL PRACTICE
Using Digital Imaging to Select Tumor Cells for NGS
Kenneth J. Bloom, M.D., Chief Medical Officer, Laboratory and Genomic Services, GE Healthcare
Data Intensive Modeling of Biomedical Processes in Computational Pathology
Jonas S. Almeida, Ph.D., Professor and Division Director, Pathology, University of Alabama Birmingham
Clinical Performance and Regulatory Considerations for in vitro Diagnostic Use of Whole Slide Imaging in the U.S.
Michael C. Montalto, Ph.D., Senior Vice President, Clinical, Medical & Scientific Affairs, GE Healthcare
